Su1127 MYOSTATIN CONTRIBUTES TO ALTERATIONS IN METABOLIC PATHWAYS AND MUSCLE ATROPHY IN MASH AND HCC AND IS A PROMISING BIOMARKER WITH METABOLIC MARKER PKM2 FOR RISK STRATIFICATION OF HCC

Krishanu Bhowmick,Xiyan Xiang,Kazufumi Ohshiro,Richard L. Amdur,Xiaochun Yang,Linda L. Wong,Kirti Shetty,Patricia S. Latham,Lawrence Lau,Keith A. Crandall,Paolo Cifani, Fellanza Cacaj,Bibhuti Mishra,Srinivasan Dasarathy,Xin W. Wang,Herbert Yu,Zhanwei Wang,Adrian R. Krainer,Sanjaya K. Satapathy,James M. Crawford

Gastroenterology（2024）

Cited 0|Views46

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined